Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NFYS Stock Summary
Top 10 Correlated ETFs
NFYS
In the News
NFYS Financial details
Company Rating
Neutral
Market Cap
444.19M
Income
10.21M
Revenue
0
Book val./share
-0.44
Cash/share
0
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
34.82
Forward P/E
-
PEG
1.47
P/S
-
P/B
-23.42
P/C
-
P/FCF
-647.22
Quick Ratio
0.01
Current Ratio
1.16
Debt / Equity
-1.02
LT Debt / Equity
-
-
-
EPS (TTM)
0.37
EPS next Y
-
EPS next Q
-
EPS this Y
545.45%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-30.77%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
100%
Inst Trans
0%
ROA
3%
ROE
4%
ROC
0.04%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
43.13M
Shs Float
22M
-
-
-
-
Target Price
-
52W Range
9.6-10.595
52W High
+3.2%
52W Low
+14.67%
RSI
69
Rel Volume
0.02
Avg Volume
56.23K
Volume
909
Perf Week
0.19%
Perf Month
0.88%
Perf Quarter
4.03%
Perf Half Y
4.14%
-
-
-
-
Beta
-
-
-
Volatility
0.01%, 0.03%
Prev Close
0%
Price
10.32
Change
0%
NFYS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2021-12-31 | 2022-12-31 |
---|---|---|---|
Revenue per share | 0 | 0 | |
Net income per share | 0.11 | 0.71 | |
Operating cash flow per share | -0.01 | -0.01 | |
Free cash flow per share | -0.01 | -0.01 | |
Cash per share | 0.02 | 0.01 | |
Book value per share | 7.45 | 9.74 | |
Tangible book value per share | 7.45 | 9.74 | |
Share holders equity per share | 7.45 | 9.74 | |
Interest debt per share | -0.06 | -0.28 | |
Market cap | 415.72M | 346.04M | |
Enterprise value | 414.9M | 345.76M | |
P/E ratio | 87.19 | 14.13 | |
Price to sales ratio | 0 | 0 | |
POCF ratio | -710.07 | -787.56 | |
PFCF ratio | -710.07 | -787.56 | |
P/B Ratio | 1.29 | 1.03 | |
PTB ratio | 1.29 | 1.03 | |
EV to sales | 0 | 0 | |
Enterprise value over EBITDA | 204.74 | -20.77 | |
EV to operating cash flow | -708.68 | -786.94 | |
EV to free cash flow | -708.68 | -786.94 | |
Earnings yield | 0.01 | 0.07 | |
Free cash flow yield | 0 | 0 | |
Debt to equity | 0.08 | 0.04 | |
Debt to assets | 0.07 | 0.04 | |
Net debt to EBITDA | -0.4 | 0.02 | |
Current ratio | 4.94 | 1.86 | |
Interest coverage | 0.26 | -0.53 | |
Income quality | -0.29 | -0.03 | |
Dividend Yield | 0 | 0 | |
Payout ratio | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | |
Research and developement to revenue | 0 | 0 | |
Intangibles to total assets | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | |
Capex to revenue | 0 | 0 | |
Capex to depreciation | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | |
Graham number | 4.3 | 12.47 | |
ROIC | 0 | 0.02 | |
Return on tangible assets | 0.01 | 0.07 | |
Graham Net | -0.57 | -0.42 | |
Working capital | 947.79K | 219.34K | |
Tangible asset value | 321.14M | 335.96M | |
Net current asset value | -24.08M | -14.21M | |
Invested capital | 0 | 0 | |
Average receivables | 0 | 50K | |
Average payables | 0 | 143.04K | |
Average inventory | 0 | 0 | |
Days sales outstanding | 0 | 0 | |
Days payables outstanding | 0 | 0 | |
Days of inventory on hand | 0 | 0 | |
Receivables turnover | 0 | 0 | |
Payables turnover | 0 | 0 | |
Inventory turnover | 0 | 0 | |
ROE | 0.01 | 0.07 | |
Capex per share | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0.27 | 0.03 | 0.07 | 0.09 | 0.08 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | -0.01 | |
Free cash flow per share | 0 | 0 | 0 | 0 | -0.01 | |
Cash per share | 0.02 | 0.01 | 0.01 | 0.01 | 0 | |
Book value per share | 7.58 | 7.61 | 7.72 | 9.74 | -0.44 | |
Tangible book value per share | 7.58 | 7.61 | 7.72 | 9.74 | 9.82 | |
Share holders equity per share | 7.58 | 7.61 | 7.72 | 9.74 | -0.44 | |
Interest debt per share | -0.27 | 0 | 0 | 0.05 | 0 | |
Market cap | 415.73M | 415.29M | 420.68M | 346.04M | 352.25M | |
Enterprise value | 414.85M | 414.69M | 420.3M | 345.76M | 352.24M | |
P/E ratio | 9.04 | 85.23 | 34.05 | 27.92 | 31.44 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -18.51K | -3.47K | -2.21K | -3.24K | -1.31K | |
PFCF ratio | -18.51K | -3.47K | -2.21K | -3.24K | -1.31K | |
P/B Ratio | 1.27 | 1.27 | 1.26 | 1.03 | -23.21 | |
PTB ratio | 1.27 | 1.27 | 1.26 | 1.03 | -23.21 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -68.78 | -206.74 | -123.71 | -99.91 | 125.75 | |
EV to operating cash flow | -18.47K | -3.47K | -2.21K | -3.23K | -1.31K | |
EV to free cash flow | -18.47K | -3.47K | -2.21K | -3.23K | -1.31K | |
Earnings yield | 0.03 | 0 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.06 | 0.06 | 0.04 | 0.04 | -1.02 | |
Debt to assets | 0.06 | 0.05 | 0.04 | 0.04 | 0.04 | |
Net debt to EBITDA | 0.14 | 0.3 | 0.11 | 0.08 | 0 | |
Current ratio | 2.96 | 2.04 | 2.4 | 1.86 | 1.16 | |
Interest coverage | 0.02 | 0 | 0 | 3.04 | 0 | |
Income quality | 0 | -0.1 | -0.04 | -0.03 | -0.1 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 6.74 | 2.2 | 3.53 | 4.44 | 0.9 | |
ROIC | 0 | 0 | 0.01 | 0.01 | 0.01 | |
Return on tangible assets | 0.03 | 0 | 0.01 | 0.01 | 0.01 | |
Graham Net | -0.43 | -0.41 | -0.34 | -0.42 | -0.45 | |
Working capital | 755.35K | 445.03K | 375.25K | 219.34K | 37.41K | |
Tangible asset value | 326.8M | 328.02M | 332.86M | 335.96M | 338.76M | |
Net current asset value | -18.48M | -17.57M | -14.27M | -14.21M | -15.18M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 99.89K | 293.47K | 325.13K | 256.42K | 124.88K | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.04 | 0 | 0.01 | 0.01 | -0.18 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
NFYS Frequently Asked Questions
What is Enphys Acquisition Corp. stock symbol ?
Enphys Acquisition Corp. is a US stock , located in New york of Ny and trading under the symbol NFYS
What is Enphys Acquisition Corp. stock quote today ?
Enphys Acquisition Corp. stock price is $10.32 today.
Is Enphys Acquisition Corp. stock public?
Yes, Enphys Acquisition Corp. is a publicly traded company.